January 26, 2015 2:08 PM
Private sector engages The Metabolomics Innovation Centre
Michelle Rempel, the , Minister of State for Western Economic Diversification announced last week an investment of $2,983,800 towards state-of-the-art metabolomics assessment equipment to be housed at
the Metabolomics Innovation Centre at the University of Alberta. The equipment will help the TMIC expands commercial services to test, validate, and assemble prototype kits to cost-effectively create more accurate and less invasive medical tests.
Minister Rempel has a background in innovation and IP, and talked about success in commercializing academic research here
immediately after the announcement.
As a measure of the commercial demand to get metabolomics research out of the lab and into the marketplace, Cell MedX Corp announced today
that it will use The Metabolomics Innovation Centre to conduct metabolomics profiling of blood samples collected during the discovery phase of a pilot trial which CellMedX started on January 9.
Cell MedX Corp
. is an early development stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications.
January 22, 2015 11:05 AM
Federal Government Supports New Metabolomics Technology Demonstration Centre
Media Release, Edmonton, January 22, 2015 -
The Honourable Michelle Rempel, Minister of State for Western Economic Diversification, today announced an investment of $2,983,800 towards state-of-the-art metabolomics assessment equipment to strengthen western Canadian companies’ ability to commercialize new discoveries.
This announcement reinforces Alberta’s position as a global leader in the emerging metabolomics market enabling Genome Alberta
, together with the University of Alberta
, to establish the Metabolomics Technology Demonstration Centre.
The equipment, a 700 MHz Nuclear Magnetic Resonance machine and a Quadrupole-Time of Flight Mass Spectrometer, will assist companies in the metabolomics sector move biomarkers from the research lab to the medical testing facility. Companies will test, validate, and assemble prototype kits using existing research from the University’s Metabolomics Innovation Centre’s
biomarker panels, to cost-effectively create more accurate and less invasive medical tests.
In addition to an investment from the National Institute of Nanotechnology, Alberta Innovates Health Solutions
, Metabolomics Technologies Inc
. (MTI), and Genome Canada
are also contributors towards this project.
January 20, 2015 2:23 PM
Centre of the metabolomic universe can be found at the University of Alberta
n - stuff out.
That's pretty much a basic fact of life for people and it holds true right on down to the basic cellular level.
If you start to compare what a healthy organism takes in, how it is broken down, and what comes out as waste you're getting close to the science of metabolomics. Figure out how the process differs in healthy organisms vs diseased organisms and you start to develop a diagnostic tool.
That's been the life's work of David Wishart who now heads up The Metabolomics Innovation Centre
at the University of Alberta. His work and the applied research taking place at the Centre have put Edmonton onto a world stage where metabolomics is the rising star playing a role in new therapies and treatments.
Journalist Don Hill talked with Dr. Wishart about metabolomics and TMIC and sent us this report.
(you might want to note the part about tricorders - Star Trek is getting closer! )
August 28, 2014 1:14 PM
The Score Lands in Canada's Science Culture
is a play that brings together science, art, music and dance.
It became a movie
that earned a Gemini nomination for its photography and music score, a Best Movie of the Week nomination at the Banff Television Awards, and a Leo nomination for Best Musical Score in a Feature Length Film. And now the obscure 2005 movie has found a spot in the Council of Canadian Academies report on science culture
The original play was commissioned in 1999 by geneticist Dr. Michael Hayden of the Centre for Molecular Medicine and Therapeutics
and was created by Electric Company Theatre
June 26, 2014 10:13 PM
An impromptu social media discussion at BIO 2014
A few years ago at BIO in Atlanta I was part of a 'Think & Drink' panel discussion that included Mary Canady, founder of Comprendia
a life sciences marketing company here in San Diego. With BIO 2014 in sunny San Diego it was no surprise that Mary was at the event and when I saw her we started talking about, what else, social media. We both attended the Monday session "Like, Share, and Tweet Your Way to Change
" and talked about whether social media had made any real inroads into the biotech sector since our panel session in Atlanta.
The good news is that the use of social media in the life science in general is increasing though it probably is still considered an emerging trend. A simple look around the online world surrounding BIO this year shows a leap forward since our panel. More blogs, more tweets, more Instagram pictures. Considering the highly regulated nature of much of the biotech industry it is also good news to see companies such as Eli Lily loosen things up with its @LillyPad
Twitter account and associated website
. They even have a Canadian @LillyPadCA
account and site
!The flipside is that social media use in biotech or even science in general is not keeping pace. At least not from the scientists or the industry.